Literature DB >> 7742534

Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences.

A Madan1, C Lin, S L Hatch, P T Curtin.   

Abstract

Erythropoietin (Epo) gene expression in kidney and liver is inducible by anemia. To localize the sequences necessary for regulated expression of the Epo gene, we constructed transgenic mice containing five human Epo gene constructs and examined Epo expression under basal conditions and with anemia. Mice containing the Epo gene with 0.3 kb of 5' flanking sequence, 0.7 kb of 3' flanking sequence, and either all introns or only intron I alone were polycythemic, had Epo expression in various tissues (including non-Epo-producing tissues), and induction only in liver. In contrast, mice containing the Epo gene with 8.5 kb of 3' flanking sequence and either 9.5 or 22 kb of 5' flanking sequence had basal expression at low levels in appropriate tissues and were less likely to be markedly polycythemic. Mice with the smaller of these two constructs had induction only in the liver, whereas those with the larger construct had induction in the kidney and liver. These studies indicate that sequences sufficient for induction in the liver are located in close proximity to the Epo gene, including the immediate 5' and 3' flanking sequence and the first intron. They also indicate that sequences required for induction in the kidney are located more than 9.5 kb 5' to the gene. Furthermore, comparison of these and prior transgenic studies suggest that sequences that limit the basal expression of the Epo gene are located downstream of the gene. We conclude that multiple cis DNA sequences are required for regulated Epo gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742534

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models.

Authors:  Johannes Vogel; Max Gassmann
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

2.  Bovine alpha s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of transgenic mice.

Authors:  M Uusi-Oukari; J M Hyttinen; V P Korhonen; A Västi; L Alhonen; O A Jänne; J Jänne
Journal:  Transgenic Res       Date:  1997-01       Impact factor: 2.788

3.  Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements.

Authors:  Ikuo Hirano; Norio Suzuki; Shun Yamazaki; Hiroki Sekine; Naoko Minegishi; Ritsuko Shimizu; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

4.  Specific contribution of the erythropoietin gene 3' enhancer to hepatic erythropoiesis after late embryonic stages.

Authors:  Norio Suzuki; Naoshi Obara; Xiaoqing Pan; Miho Watanabe; Kou-Ichi Jishage; Naoko Minegishi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

5.  In vivo analysis of DNA-protein interactions on the human erythropoietin enhancer.

Authors:  B Hu; E Wright; L Campbell; K L Blanchard
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

6.  Gene therapy for long-term expression of erythropoietin in rats.

Authors:  W R Osborne; N Ramesh; S Lau; M M Clowes; D C Dale; A W Clowes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 7.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

8.  Differential expression of lacZ in the liver and kidney of transgenic mice carrying chimeric lacZ-erythropoietin gene constructs with or without its 1.2 kb 3'-flanking sequence.

Authors:  M A Haidar; F Loya; Y Yang; H Lin; A Glassman; M J Keating; E Goldwasser; M Albitar
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

Review 9.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

Review 10.  Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.

Authors:  Nicole Rainville; Edward Jachimowicz; Don M Wojchowski
Journal:  Expert Opin Ther Targets       Date:  2015-09-30       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.